BiotechTube
Gestalt Diagnostics

Gestalt Diagnostics

Spokane, United States· Est.
gestaltdiagnostics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $14.5M

Overview

Gestalt Diagnostics is a private company founded in 2017, headquartered in Spokane, Washington. It offers a comprehensive suite of digital pathology solutions centered on its PathFlow platform, augmented by AI applications and a robust portfolio of healthcare IT services. The company positions itself as an enterprise-ready, secure, and interoperable partner for labs undergoing digital transformation, with a strong emphasis on clinical utility, compliance (SOC 2, HIPAA, CE-IVD), and seamless integration with existing hospital IT ecosystems. Its business model is focused on providing diagnostic software and services, generating revenue through platform deployments and IT service contracts.

Diagnostics

Technology Platform

PathFlow digital pathology platform unifying image, case, and patient management, integrated with AI applications and supported by PathCloud for web-based collaboration and a suite of healthcare IT services.

Funding History

2
Total raised:$14.5M
Series A$12M
Seed$2.5M

Opportunities

The accelerating enterprise-wide adoption of digital pathology creates demand for integrated, scalable platforms.
The chronic strain on healthcare IT departments presents a major opportunity for Gestalt's differentiated IT services and staff augmentation model.
Growing regulatory acceptance of AI for clinical diagnostics allows for expansion of its AI portfolio into new disease areas and applications.

Risk Factors

Faces intense competition from large, established medtech firms and agile AI startups in the digital pathology software space.
Its service-heavy model, while a differentiator, carries execution risks related to scalability and margin management.
The pace of overall digital pathology adoption by laboratories could be slower than anticipated, impacting growth.

Competitive Landscape

Gestalt competes in the digital pathology software market against large players like Philips, Roche (Ventana), and Sectra, which offer comprehensive platforms, and against numerous specialized AI software startups. Its key differentiator is the combination of its clinical workflow platform with a deep portfolio of healthcare IT professional services, positioning it as an implementation partner rather than just a software vendor.

More companies in Diagnostics & Precision Medicine →More companies in United States →